ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 114 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $10 | 0.0% | 14,498 | -15.6% | 0.00% | 0.0% |
| Q4 2022 | $10 | -100.0% | 17,174 | -76.8% | 0.00% | -96.0% |
| Q2 2021 | $259,000 | +15.6% | 73,955 | +257.9% | 0.02% | +4.2% |
| Q4 2020 | $224,000 | -33.1% | 20,665 | -36.5% | 0.02% | -57.9% |
| Q3 2020 | $335,000 | -40.4% | 32,527 | +20.8% | 0.06% | -12.3% |
| Q2 2020 | $562,000 | +473.5% | 26,924 | +49.9% | 0.06% | +712.5% |
| Q3 2019 | $98,000 | +48.5% | 17,964 | -13.9% | 0.01% | +100.0% |
| Q4 2018 | $66,000 | -43.6% | 20,862 | +3.7% | 0.00% | -33.3% |
| Q1 2018 | $117,000 | +120.8% | 20,123 | +38.1% | 0.01% | +100.0% |
| Q3 2017 | $53,000 | – | 14,575 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,112,355 | $40,178,000 | 34.81% |
| Versant Venture Management, LLC | 7,068,233 | $69,056,636,000 | 18.94% |
| ACUTA CAPITAL PARTNERS, LLC | 1,704,500 | $16,653,000 | 8.07% |
| Soleus Capital Management, L.P. | 313,900 | $3,067,000 | 3.57% |
| Ghost Tree Capital, LLC | 1,305,500 | $12,755,000 | 3.38% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $4,690,000 | 2.97% |
| RTW INVESTMENTS, LP | 6,631,627 | $64,791,000 | 2.79% |
| VR Adviser, LLC | 994,381 | $9,715,000 | 2.63% |
| Avoro Capital Advisors LLC | 7,150,000 | $69,856,000 | 2.36% |
| RA Capital Management | 7,272,714 | $71,054,000 | 2.24% |